Business Wire

IMV to Participate in the BTIG Virtual Biotechnology Conference

DARTMOUTH, Nova Scotia--(BUSINESS WIRE)--IMV Inc. (“IMV” or the “Corporation”) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of immunotherapies against difficult-to-treat cancers, today announced that


Biomind Labs Begins Trading on the NEO Exchange

TORONTO--(BUSINESS WIRE)--$BMND #Biomind--Today, NEO welcomes its newest corporate listing partner, Biomind Labs Inc. (“Biomind”), as it makes its public markets debut on the NEO Exchange. A biotechnology research and development company specializing